The Recall Desk
CriticalFDA (Devices)·Z-2592-2021·Announced 2021-10-06

Atrium Pneumostat Chest Drain Valve Recalled Following Fatal Preterm Infant Case

Atrium Medical Corporation is recalling 92,430 units of its Pneumostat Chest Drain Valve after a preterm infant died during treatment with the device. The company is revising product labeling and warnings.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The source reports a death: a preterm infant died following treatment with this device. Per the FDA severity rubric, reported deaths result in a Critical (5) classification regardless of other factors.

Plain-English summary

Atrium Medical Corporation is recalling the Pneumostat Chest Drain Valve, Part Number 16100. Approximately 92,430 units have been distributed domestically throughout the United States and internationally worldwide.

The recall was initiated after the device was involved in the treatment of a preterm infant who died. In response, Atrium Medical Corporation is revising the device's Indication for Use, Contraindications, Warnings, and Precautions.

The recall affects multiple product lots as documented in the FDA safety notice Z-2592-2021.

The recalled product

Product
Atrium Pneumostat Chest Drain Valve, Part Number 16100
Manufacturer
Atrium Medical Corporation
Hazard
  • device-malfunction
  • inadequate-labeling

Distribution

Distributed nationwide across the United States.